## Clinical Diagnosis **Key Point:** The CSF profile (low glucose, high protein, neutrophil predominance) and gram-negative diplococci on Gram stain are pathognomonic for *Neisseria meningitidis* (meningococcal meningitis). ## Empiric Antibiotic Regimen **High-Yield:** In bacterial meningitis, empiric therapy must cover: - *Streptococcus pneumoniae* (most common in adults) - *Neisseria meningitidis* (second most common) - *Listeria monocytogenes* (in immunocompromised, age >50, or neonates) The **gold standard empiric regimen** is: | Drug | Dose | Rationale | | --- | --- | --- | | **Ceftriaxone** | 2 g IV 12-hourly (4 g/day total) | Excellent CSF penetration; covers pneumococci and meningococci | | **Vancomycin** | 15–20 mg/kg IV 8–12-hourly | Added for penicillin-resistant *S. pneumoniae*; synergistic with cephalosporin | **Clinical Pearl:** Vancomycin is added empirically in all meningitis cases until susceptibilities are known, because penicillin-resistant pneumococcal meningitis carries high mortality if vancomycin is delayed. **Mnemonic: "CVL for Meningitis"** — **C**eftriaxone, **V**ancomycin, **L**isteria coverage (ampicillin if age >50 or immunocompromised). ## Why This Patient Fits the Regimen Although Gram stain shows gram-negative diplococci (suggesting meningococcal meningitis), empiric therapy must still include vancomycin and cephalosporin because: 1. Cultures take 24–48 hours; clinical diagnosis is not 100% certain. 2. Co-infection or misidentification on Gram stain can occur. 3. Meningococcal meningitis itself has improved outcomes with cephalosporin + vancomycin. [cite:Harrison 21e Ch 383]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.